Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Targeted detection of tricarboxylic acid (TCA) cycle intermediates enables absolute quantification of citrate, alpha-ketoglutarate, succinate, fumarate, malate, and related metabolites with high sensitivity and specificity. Based primarily on LC-MS/MS with stable isotope-labeled internal standards, this approach is widely used in cancer metabolism research, mitochondrial disease diagnosis, immunometabolism, and metabolic engineering. This article outlines the technical principles, sample requirements, analytical workflow, and typical applications of TCA cycle intermediate profiling.

Technical Overview

The tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, is the central hub of cellular oxidative metabolism. Located in the mitochondrial matrix, it oxidizes acetyl-CoA derived from carbohydrates, fatty acids, and amino acids to carbon dioxide while generating NADH and FADH2 that feed the electron transport chain. Beyond energy production, TCA cycle intermediates continuously exchange with biosynthetic pathways, serving as precursors for amino acids, nucleotides, heme, and lipids through anaplerotic and cataplerotic reactions.

Because the concentrations of these intermediates respond sensitively to enzyme mutations, hypoxia, substrate availability, immune activation, and drug exposure, their accurate measurement provides a direct readout of mitochondrial function and metabolic reprogramming. Unlike untargeted metabolomics, targeted detection focuses on a predefined panel of metabolites and uses authentic chemical standards together with stable isotope-labeled internal standards, delivering absolute quantification with high accuracy and reproducibility, typically across nanomolar to millimolar concentration ranges.

A well-designed targeted assay must overcome several well-recognized analytical challenges:

  • High polarity and poor retention of short-chain di- and tricarboxylic acids on conventional reversed-phase columns.
  • Structural isomers, such as citrate and isocitrate, that share identical masses and require dedicated chromatographic separation.
  • Chemical instability of keto acids, particularly oxaloacetate, which decarboxylates readily, and CoA thioesters, which are prone to hydrolysis.
  • Extremely rapid post-sampling metabolism, which demands instantaneous quenching of enzymatic activity during sample collection.
  • A wide concentration span among intermediates, requiring broad linear calibration ranges and careful detector dynamic range management.

These challenges are addressed through optimized quenching and extraction protocols, selective chromatography, isotope dilution quantification, and rigorous quality control throughout the workflow.

Testing Samples

Targeted TCA cycle assays are compatible with a broad range of biological matrices. Because pathway intermediates turn over within seconds, sample collection and stabilization protocols are as important as the analytical measurement itself.

Cell Samples

Cultured mammalian cells, organoids, primary cells, and suspension cell lines are the most frequently submitted matrices. Metabolism is halted by rapid washing with cold isotonic solution followed by immediate quenching with pre-chilled extraction solvent, typically 80% methanol at −80°C. A minimum of one to five million cells per sample is generally recommended, with results normalized to cell number, total protein, or DNA content. Cell pellets should be snap-frozen in liquid nitrogen if extraction cannot be performed immediately.

Animal Tissue Samples

Liver, heart, brain, skeletal muscle, kidney, adipose tissue, and tumor xenografts are routinely analyzed. Approximately 20 to 100 mg of tissue should be dissected rapidly, rinsed briefly to remove blood contamination, and flash-frozen in liquid nitrogen. Tissues are homogenized under cold conditions in extraction solvent containing internal standards, and repeated freeze–thaw cycles must be avoided to prevent artificial metabolite degradation.

Body Fluid Samples

Plasma, serum, urine, and cerebrospinal fluid are well suited for clinical and translational studies. Typical input volumes are 50 to 100 µL. Protein precipitation with cold organic solvent is performed before analysis, and urine results are commonly normalized to creatinine. Blood samples should be processed quickly at low temperature to minimize ex vivo glycolytic and TCA flux changes.

Plant and Microbial Samples

Leaves, roots, seeds, fruits, and fermentation broths can all be analyzed. Plant tissues of 100 to 200 mg fresh weight are ground under liquid nitrogen before cold solvent extraction. Microbial cultures require especially stringent quenching, typically by rapid dilution into pre-chilled methanol, because microbial metabolic rates are extremely high and intermediates can change within seconds of sampling.

Isolated Mitochondria and Subcellular Fractions

For compartment-specific studies, isolated mitochondria, cytosolic fractions, or peroxisomal preparations can be submitted. Isolation must be fast and cold to preserve metabolite gradients, and results are normalized to organelle protein content. Investigators should note that some metabolic redistribution can occur during organelle isolation.

Testing Items

The standard panel covers the canonical intermediates of the cycle together with closely connected entry-point metabolites and pathway-derived biomarkers:

  • Citric acid (citrate)
  • Isocitric acid (isocitrate)
  • Alpha-ketoglutaric acid (2-oxoglutaric acid)
  • Succinyl-CoA (where sample type and stability permit)
  • Succinic acid (succinate)
  • Fumaric acid (fumarate)
  • Malic acid (malate)
  • Oxaloacetic acid (oxaloacetate, semi-quantitative in most workflows)

Frequently requested companion analytes that extend the biological interpretability of the panel include:

  • Pyruvic acid and lactic acid, reflecting glycolytic entry and cytosolic redox balance
  • Acetyl-CoA, free coenzyme A, and acetylcarnitine
  • Cis-aconitic acid and itaconic acid, key markers of activated macrophage metabolism
  • D-2-hydroxyglutaric acid and L-2-hydroxyglutaric acid, established oncometabolites
  • Glutamic acid, glutamine, and aspartic acid, reflecting anaplerotic and transaminase connections
  • Methylmalonic acid and malonyl-CoA for related organic acid and fatty acid synthesis disorders

Deliverables typically include absolute concentrations, reported as µmol/L for fluid samples and nmol per mg protein or nmol per million cells for cellular and tissue samples, as well as diagnostic ratios such as succinate-to-fumarate, lactate-to-pyruvate, and citrate-to-alpha-ketoglutarate. For isotope tracing studies, mass isotopomer distributions of each intermediate can additionally be reported.

Testing Methods

Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is the current method of choice, supplemented by GC-MS and ion chromatography options depending on analyte chemistry and study objectives.

LC-MS/MS with Stable Isotope Dilution

Target analytes are separated on hydrophilic interaction chromatography (HILIC), ion-exclusion, or anion-exchange columns and detected on a triple quadrupole mass spectrometer operated in negative electrospray ionization mode with multiple reaction monitoring (MRM). Stable isotope-labeled analogs of each metabolite are spiked into samples before extraction, correcting for matrix effects, extraction losses, and instrument drift. Optional derivatization with 3-nitrophenylhydrazine dramatically improves retention and ionization efficiency for carboxylic acids, lowering detection limits by one to two orders of magnitude. Well-validated assays achieve lower limits of quantification in the low nanomolar range with intra-day precision typically below 15%.

GC-MS After Derivatization

Gas chromatography–mass spectrometry remains a classical and robust alternative. Organic acids are converted to trimethylsilyl derivatives after oximation, providing excellent chromatographic resolution of structural isomers and access to comprehensive spectral libraries. Limitations include lengthy derivatization steps, sensitivity of keto acids to degradation, and unsuitability for thermally labile CoA thioesters.

Ion Chromatography and HPLC Alternatives

Ion chromatography with hydroxide gradient elution offers outstanding separation of organic acid anions and can be coupled to suppressed conductivity detection or mass spectrometry. Conventional HPLC with UV detection at low wavelengths is suitable for matrices where analyte concentrations are high, while capillary electrophoresis–MS provides an additional option for highly polar intermediates.

Sample Preparation Workflow

A typical LC-MS/MS workflow proceeds as follows:

  • Rapid quenching of metabolism using pre-chilled solvents or liquid nitrogen.
  • Cold solvent extraction, commonly 80:20 methanol–water or methanol–acetonitrile–water mixtures, with isotope-labeled internal standards added at the start.
  • Homogenization, vortexing, and incubation at low temperature to maximize recovery.
  • Centrifugation to pellet proteins and debris, followed by supernatant collection.
  • Drying under nitrogen and reconstitution in a solvent matched to the starting LC conditions.
  • LC-MS/MS injection with pooled quality-control samples run at regular intervals.

Quality assurance measures include matrix-matched calibration curves, pooled QC injections every eight to ten study samples, system suitability tests, carryover assessment, and blank-subtraction verification.

Applications

Cancer Metabolism and Oncometabolite Research

Accumulation of specific TCA intermediates acts as a hallmark of defined tumor genotypes. Succinate builds up in succinate dehydrogenase-mutant paragangliomas and gastrointestinal stromal tumors, fumarate accumulates in fumarate hydratase-deficient renal and uterine cancers, and D-2-hydroxyglutarate is produced by mutant IDH1 and IDH2 in gliomas and acute myeloid leukemia. Targeted panels allow researchers to monitor oncometabolite dynamics, evaluate responses to IDH inhibitors such as enasidenib and ivosidenib, and study reductive carboxylation and glutamine addiction in hypoxic tumors.

Mitochondrial Disease and Inherited Metabolic Disorders

Quantification of TCA intermediates in plasma, urine, and cerebrospinal fluid supports the biochemical workup of organic acidemias, fumarase deficiency, alpha-ketoglutarate dehydrogenase defects, and mitochondrial respiratory chain dysfunction. Elevated succinate has been proposed as a circulating biomarker of mitochondrial stress, and intermediate profiles complement enzymatic and genetic testing in diagnostic pipelines.

Immunometabolism and Inflammation

Succinate functions as a pro-inflammatory signal acting through its receptor SUCNR1 and by stabilizing HIF-1α in activated immune cells, while itaconate, derived from cis-aconitate, exerts anti-inflammatory and antimicrobial effects in macrophages. Measuring these metabolites provides mechanistic insight into inflammasome activation, sepsis, autoimmune disease, and macrophage polarization studies.

Metabolic Engineering and Fermentation Monitoring

Engineered microbial strains are widely used for the biosynthesis of succinate, malate, fumarate, and itaconate. Targeted detection quantifies pathway intermediates and product titers in fermentation broths, guides rational strain improvement, and supplies labeling data for 13C-based metabolic flux analysis that maps carbon distribution through the cycle.

Plant Physiology and Agricultural Science

Organic acid profiles underpin studies of crassulacean acid metabolism, drought and salinity stress responses, nitrogen assimilation, post-harvest respiration, and fruit quality, making targeted TCA analysis valuable across crop science and plant biotechnology.

Pharmacology and Toxicology

Drug candidates that impair mitochondrial function often cause characteristic shifts in TCA intermediate pools. Targeted profiling is therefore used in preclinical safety assessment to flag mitochondrial toxicity early and to characterize metabolism-targeted therapeutics under development.

FAQ

Why must TCA cycle samples be quenched immediately?

TCA intermediates turn over within seconds because the responsible enzymes remain active after sampling. Any delay allows artificial consumption or production of metabolites, distorting the in vivo picture. Quenching with pre-chilled 80% methanol at −80°C or flash-freezing in liquid nitrogen preserves metabolite levels as they existed at the moment of collection.

How are structural isomers such as citrate and isocitrate distinguished?

Isomers like citrate and isocitrate have identical molecular masses and very similar fragmentation patterns, so mass spectrometry alone cannot separate them. Reliable discrimination requires chromatographic resolution using HILIC, anion-exchange, or ion-exclusion methods. If separation is not achieved, the analytes are reported as a combined total.

Why is oxaloacetate usually reported only semi-quantitatively?

Oxaloacetate is chemically unstable in biological extracts, undergoing spontaneous decarboxylation to pyruvate and rapid enzymatic conversion to malate or aspartate during handling. These properties make strict quantification unreliable, so malate and aspartate are often interpreted together with oxaloacetate as indicators of the related metabolite pool.

What sample quantities are required?

Typical minimum inputs are one to five million cells per sample, 20 to 100 mg of tissue, 50 to 100 µL of plasma, serum, or urine, and 100 to 200 mg fresh weight of plant material. Requirements may vary by matrix and panel scope, so investigators should confirm specifics with the testing laboratory before collection.

Can CoA thioesters be quantified in the same assay?

Succinyl-CoA and acetyl-CoA are chemically distinct from the free organic acids and degrade rapidly under neutral or basic conditions. They require a dedicated acidic extraction protocol and, in many laboratories, a separate chromatographic method, so they are generally offered as a companion panel rather than within the standard organic acid assay.

How should samples be stored and shipped?

Quenched extracts and frozen tissues should be stored at −80°C and shipped on dry ice with temperature monitoring. Repeated freeze–thaw cycles must be avoided, and no preservatives should be added to urine unless specifically agreed with the laboratory in advance.

What quality control measures are applied?

Validated assays incorporate isotope dilution internal standards, matrix-matched or surrogate calibration curves, pooled QC samples injected every eight to ten study samples, acceptance criteria of coefficient of variation below 15% (and below 20% at the lower limit of quantification), plus carryover and blank assessments to guarantee data integrity.